Clinical trial
A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS)…
NCT00410514 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00410514 |
|---|---|
| Title | A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO) |
| Official title | A Phase 2, Randomized, Double-blind, Parallel Group, Placebo Controlled, Multi-center Study to Evaluate the Urodynamics and Safety of YM178 in Male Subjects With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO) |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lower Urinary Tract Symptoms, Bladder Outlet Obstruction |
| Intervention type | Drug |
| Interventions | Mirabegron, Placebo |
| Enrollment | 200 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Dec 13, 2006 |
| Last update posted | Apr 4, 2014 |
| Countries | Canada, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: